Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Summaries of opinion Remove Summaries of opinion filter Withdrawn applications Remove Withdrawn applications filter Maximum residue limits Remove Maximum residue limits filter Referrals Remove Referrals filter European public assessment reports (EPAR) (45) Apply European public assessment reports (EPAR) filter Paediatric investigation plans (10) Apply Paediatric investigation plans filter Orphan designations (23) Apply Orphan designations filter Direct healthcare professional communication (3) Apply Direct healthcare professional communication filter

Product number

Date of opinion

From:

To:

Withdrawal type

Post-authorisation (1) Apply Post-authorisation filter

Withdrawal date

From:

To:

Referral name

Referral status

European Commission final decision (1) Apply European Commission final decision filter

Referral type

Article 31 referrals (1) Apply Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (1) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (1) Apply Centrally and nationally authorised products (mixed) filter

Referral PRAC recommendation

Risk minimisation measures (1) Apply Risk minimisation measures filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Medicine type

Exceptional circumstances Remove Exceptional circumstances filter Accelerated assessment (4) Apply Accelerated assessment filter Additional monitoring (43) Apply Additional monitoring filter Biosimilar (6) Apply Biosimilar filter Conditional approval (11) Apply Conditional approval filter Generic (33) Apply Generic filter Orphan medicine (57) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

2 results

Remove all filtersRemove all filters

Medicine Maximum residue limits Remove Maximum residue limits filter Withdrawn applications Remove Withdrawn applications filter Referrals Remove Referrals filter Summaries of opinion Remove Summaries of opinion filter

Categories Human Remove Human filter

Medicine type Exceptional circumstances Remove Exceptional circumstances filter

Sort by

List item

Withdrawn application: Evoltra

clofarabine, date of withdrawal: 18/03/2008, Post-authorisation, Last updated: 19/03/2008
List item

Referral: Factor VIII

associated names: Iblias, Elocta, Kovaltry, Nuwiq, Obizur, NovoEight, Voncento, ReFacto AF, Kogenate Bayer, Helixate NexGen, Advate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/09/2017, EC decision date: 10/10/2017, Last updated: 05/12/2017

2 results

Withdrawn application: Evoltra

Referral: Factor VIII